Palobiofarma

Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. The company offers virtual drug design, medicinal chemistry, in-vitro pharmacology exper...

Healthcare

Barcelona, Spain

Founded 2005

20 employees

Website

Valuation

$79.3M

Market implied

Share Price

N/A

Total Raised

$21.1M

Last Round

N/A

Investors

+15 other investors

View all 15 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Palobiofarma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required